Growth Screening

Growth Stock Screening Criteria

Growth stock screening focuses on companies with above-average revenue and earnings expansion potential, identified through revenue trajectory analysis, EPS estimate revision momentum, analyst coverage depth, and valuation context rather than chasing price momentum alone.

Price Thresholds

Growth Stock Screening by Price Threshold

Different price thresholds apply different screening guardrails for growth stocks. Select a threshold that matches your risk tolerance and investment goals.

$10 Threshold

The $10 threshold captures early-stage growth companies that have established market presence but remain accessible. At this level, AI applies moderate liquidity filters (100K+ volume) and emphasizes revenue growth trajectory and analyst coverage quality. Many technology and healthcare growth companies screen best at this level.

$5 Threshold

The $5 threshold expands growth screening to smaller emerging companies with higher growth potential but also higher risk. AI enforces stricter volume minimums (200K+) and requires positive revenue trends. Growth stocks at this level typically have fewer covering analysts, so the AI adjusts its coverage requirements accordingly.

Penny Stock Threshold

Growth screening at the penny stock level is the highest-risk category, targeting micro-cap companies with early-stage growth trajectories. AI applies the strictest filters: $2+ price floor, 200K+ volume, $50M+ market cap, and NASDAQ/NYSE listing. The AI score for penny growth stocks weights revenue trajectory and liquidity above all other factors.

Screening Criteria

Growth Stock Screening Criteria

The AI evaluates each growth candidate against these key screening criteria. Each criterion includes the AI approach and typical threshold value.

Feature comparison table: AI Approach vs Example Value
Screening CriterionAI ApproachExample Value
Revenue Growth Rate (YoY)Year-over-year revenue growth is the primary growth quality signal. Companies growing revenue above 10% annually are typically expanding market share or benefiting from secular tailwinds; above 20% signals exceptional demand acceleration. The AI evaluates revenue growth over trailing 1-year and 3-year periods to distinguish sustainable growth from one-time spikes, and adjusts expectations by sector -- a 10% growth rate is evaluated differently for a mature industrial versus an early-stage biotech.>10-20%
EPS Growth Rate (YoY)Earnings per share growth measures how effectively revenue expansion translates to bottom-line profitability. Growth investors look for EPS growth that meets or exceeds revenue growth, confirming operating leverage and margin expansion. The AI screener evaluates trailing EPS growth alongside forward EPS estimate trends to identify companies where earnings momentum is accelerating rather than decelerating.>10-15%
PEG RatioThe price/earnings-to-growth (PEG) ratio divides the P/E multiple by the EPS growth rate, providing a growth-adjusted valuation gauge. A PEG below 1.0 suggests a stock is undervalued relative to its growth rate; below 2.0 is considered reasonable for most growth investors. The AI uses PEG as a key valuation sanity check to distinguish genuine growth opportunities from stocks where high valuation multiples have detached from underlying fundamentals.<2.0
Analyst Coverage CountA minimum of three covering analysts ensures institutional-grade research validation. More analysts mean deeper financial model scrutiny, more frequent estimate updates, and broader market awareness. The AI screener enriches each result with the actual analyst count, consensus rating (buy/hold/sell), and EPS estimate ranges, and scores stocks higher when coverage depth is accompanied by upward estimate revision momentum.3+ analysts
EPS Estimate Revision MomentumUpward EPS estimate revisions from multiple analysts over a rolling 30-to-90-day window are one of the most reliable leading indicators of accelerating fundamentals. When the analyst community raises estimates concurrently, it signals improving business conditions that may not yet be reflected in the stock price. The AI tracks both the direction and magnitude of revisions across the full analyst coverage set.Positive over 30-90 days
Return on Equity (ROE)Return on equity measures how efficiently a company generates profit from shareholder capital. High-growth companies with ROE above 15% demonstrate durable competitive advantages and effective capital allocation. The AI evaluates ROE over trailing 12 months and 3-year averages, scoring higher when ROE is both elevated and stable, as erratic ROE can signal competitive pressure or financial engineering.>15%
Debt-to-Equity RatioLow debt-to-equity is a quality filter for growth stocks, since excessive leverage amplifies downside risk during economic slowdowns and can force companies to cut growth investments to service debt. A D/E below 0.5 indicates conservative capital structure, while higher levels trigger a growth quality warning. Sector adjustments apply -- utilities and capital-intensive industries naturally carry higher leverage, but for growth screening the preference is always for asset-light, high-return business models.<0.5
Operating Margin TrendOperating margin trajectory reveals whether revenue growth is translating into real profitability or being consumed by rising costs. Growth companies with expanding operating margins demonstrate pricing power, operational efficiency, and scalable business models. The AI flags margin compression as a warning signal even when top-line revenue growth is strong, since deteriorating unit economics often precede growth slowdowns.Stable or expanding
Screening Approach

How AI Screens for Growth Stocks

Traditional growth stock screening requires manually pulling financial statements, tracking analyst revisions across individual brokerage platforms, building spreadsheet models, and checking coverage counts one ticker at a time -- a process that takes hours and typically covers only dozens of stocks.

Traditional growth stock screening requires manually pulling financial statements, tracking analyst revisions across individual brokerage platforms, building spreadsheet models, and checking coverage counts one ticker at a time -- a process that takes hours and typically covers only dozens of stocks. AI transforms this by simultaneously evaluating revenue trajectory, EPS estimate revisions from the full analyst community, analyst coverage depth, PEG ratios, ROE, debt levels, and operating margin trends across thousands of publicly traded companies in seconds. Each result is enriched with analyst EPS estimates (low, average, high projections), revenue estimate ranges, trailing financials, and a composite 1-10 growth quality score that weights revenue momentum, earnings revision breadth, valuation reasonableness, and balance sheet health together. What takes a traditional analyst an entire morning takes the AI screener a single query, with broader coverage and more consistent methodology.

FAQ

Frequently Asked Questions

Common questions about growth stock screening criteria and how AI evaluates each factor.

Related Screening Criteria

Explore other stock screening approaches to build a investment strategy.

Free to Use

Screen Growth Stocks with AI — Free

Use Pineify's free AI stock screener to find growth stocks using real-time data, analyst estimates, and AI 1-10 predictive scores based on these screening criteria. No registration required.

Try the AI Stock Screener

Past performance is not indicative of future results. AI-generated scores and stock picks are predictive in nature and are not guaranteed to produce any particular outcome or return. Nothing on this page constitutes financial advice, investment recommendation, or solicitation to buy or sell any security. All investment decisions involve risk, including the potential loss of principal. You should conduct your own independent research and consult with a qualified financial advisor before making any investment decisions. The AI model may miss or misinterpret market-moving events, and scores can change without notice.